The invention relates to veterinary pharmaceutical formulations, their preparation and their use. More particularly, the invention relates to veterinary pharmaceutical formulations including methyl 5-(dimethylamino)-2-methyl-5-oxopentanoate, their preparation and their use in methods for veterinary treatment.